Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas

Melinda S. Merchant, Donna Bernstein, Martha Amoako, Kristin Baird, Thomas A. Fleisher, Michel Morre, Seth M. Steinberg, Marianna Sabatino, D. Stroncek, Aradhana M. Venkatasan, Bradford J. Wood, Matthew Wright, Hua Zhang, Crystal L. MackallClinical 2016 · DOI

Abstract

Adjuvant immunotherapy may improve survival in patients with metastatic pediatric sarcoma. Clin Cancer Res; 22(13); 3182-91. ©2016 AACR.
BibTeX
@inproceedings{merchant2016adjuvant,
  author = {Melinda S. Merchant and Donna Bernstein and Martha Amoako and Kristin Baird and Thomas A. Fleisher and Michel Morre and Seth M. Steinberg and Marianna Sabatino and D. Stroncek and Aradhana M. Venkatasan and Bradford J. Wood and Matthew Wright and Hua Zhang and Crystal L. Mackall},
  title = {{Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas}},
  booktitle = {Clinical},
  year = {2016},
  doi = {10.1158/1078-0432.ccr-15-2550},
}

Loading related content...

Figure